Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pharmacokinetic and therapeutic equivalence of Zelapar and Eldepryl

Oct. 27, 1998

New serotonergic agents in development at ADIR for CNS disorders

Oct. 27, 1998

Yamanouchi discloses 5-HT2C receptor agonists with high potency and selectivity

Oct. 27, 1998

Korean research institute develops new NMDA receptor antagonists

Oct. 27, 1998

Agents for schizophrenia from Yoshitomi typified by Y-36074

Oct. 27, 1998

Dainippon will initiate European development of antipsychotic drug candidate

Oct. 27, 1998

Sublingual apomorphine safe and effective in PD patients with motor fluctuations

Oct. 26, 1998

Transdermal selegiline as monotherapy in mild to moderate Parkinson's disease

Oct. 26, 1998

Transdermal D2 agonist therapy with N-0923 safe and effective in PD

Oct. 26, 1998

Metabasis Therapeutics seeks partner for development of anticonvulsant

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...